Electron Paramagnetic Resonance Investigation on Modulatory Effect of 17β-Estradiol on Membrane Fluidity of Erythrocytes in Postmenopausal Women
Authors:
- 1 August 2001
- journal article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 21 (8) , 1306-1312
Abstract
Many studies have shown that estrogen may exert cardioprotective effects and reduce the risk of hypertension and coronary events. On the other hand, it has been proposed that cell membrane abnormalities play a role in the pathophysiology of hypertension, although it is not clear whether estrogen would influence membrane function in essential hypertension. The present study was performed to investigate the effects of 17β-estradiol (E 2 ) on membrane fluidity of erythrocytes in normotensive and hypertensive postmenopausal women. We determined the membrane fluidity of erythrocytes by means of an electron paramagnetic resonance and spin-labeling method. In an in vitro study, E 2 significantly decreased the order parameter for 5-nitroxide stearate and the peak height ratio for 16-nitroxide stearate obtained from electron paramagnetic resonance spectra of erythrocyte membranes in normotensive postmenopausal women. The finding indicates that E 2 might increase the membrane fluidity of erythrocytes. The effect of E 2 was significantly potentiated by the NO donor, S -nitroso- N -acetylpenicillamine, and a cGMP analogue, 8-bromo-cGMP. In contrast, the change in the membrane fluidity evoked by E 2 was attenuated in the presence of the NO synthase inhibitor, N G -nitro- l -arginine methyl ester, and asymmetric dimethyl- l -arginine. In hypertensive postmenopausal women, the membrane fluidity of erythrocytes was significantly lower than that in normotensive postmenopausal women. The effect of E 2 on membrane fluidity was significantly more pronounced in the erythrocytes of hypertensive postmenopausal women than in the erythrocytes of normotensive postmenopausal women. The results of the present study showed that E 2 significantly increased the membrane fluidity and improved the microviscosity of erythrocyte membranes, partially mediated by an NO- and cGMP-dependent pathway. Furthermore, the greater action of E 2 in hypertension might be consistent with the hypothesis that E 2 could have a beneficial effect in regulating rheological behavior of erythrocytes and could have a crucial role in the improvement of the microcirculation in hypertension.Keywords
This publication has 29 references indexed in Scilit:
- Nitric Oxide Improves Membrane Fluidity of Erythrocytes in Essential Hypertension: An Electron Paramagnetic Resonance InvestigationBiochemical and Biophysical Research Communications, 2000
- Up‐regulation of nitric oxide synthase by estradiol in human aorticendothelial cellsFEBS Letters, 1995
- Nitric oxide synthases: Roles, tolls, and controlsCell, 1994
- Postmenopausal Estrogen Therapy and Cardiovascular DiseaseNew England Journal of Medicine, 1991
- Sodium-lithium countertransport and hypertension in Rochester, Minnesota.Hypertension, 1991
- Identification of specific high affinity sites for the estradiol receptor in the erythrocyte cytoskeletonBiochemical and Biophysical Research Communications, 1981
- Increased Sodium-Lithium Countertransport in Red Cells of Patients with Essential HypertensionNew England Journal of Medicine, 1980
- Differences in membrane unsaturated fatty acids and electron spin resonance in different types of myeloid leukemia cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1979
- Estrogen receptors in uterine plasma membraneThe Journal of Steroid Biochemistry and Molecular Biology, 1979
- Abnormalities of Cell-Membrane Fluidity in the Pathogenesis of DiseaseNew England Journal of Medicine, 1977